NewsRoom Articles - Page 539 of 1390

WednesdayOct 14, 2020 11:00 am

Avicanna (TSX: AVCN) (OTCQX: AVCNF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Avicanna (TSX: AVCN) (OTCQX: AVCNF) is a commercial-stage, diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for global consumer, medical cannabis and pharmaceutical market segments. Avicanna manages its own supply chain, including cultivation and extraction, through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. These sustainable, economical, and industrial-scale subsidiaries allow Avicanna to cultivate, process, and commercialize a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Aras…

WednesdayOct 14, 2020 10:45 am

Akerna (NASDAQ: KERN) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Akerna (NASDAQ: KERN) is a Denver-based regulatory compliance technology company in the cannabis industry. The cornerstones of Akerna’s service offerings are MJ Platform® and Leaf Data Systems®, which are highly versatile platforms that provide clients and government entities with a central data management system for tracking regulated cannabis products—from seed to product and from shelf to customer—through the complete supply chain. Since establishment in 2010, the company has tracked more than $18 billion in cannabis sales across 14 countries and has served clients in 29 states across the U.S. As part of its business strategy, Akerna intends to grow through…

WednesdayOct 14, 2020 10:40 am

1933 Industries, Inc. (CSE: TGIF) (OTCQX: TGIFF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

1933 Industries, Inc. (CSE: TGIF) (OTCQX: TGIFF) is a vertically integrated growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of the value chain with cultivation, extraction, processing and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners. Having started life as the first Las Vegas-based cannabis cultivator servicing the medicinal market, 1933 Industries now boasts over 100 SKUs in their product portfolio along with 6 licensing partners. Paul Rosen, CEO of 1933 Industries, will be speaking…

WednesdayOct 14, 2020 10:35 am

4Front Ventures (CSE: FFNT) (OTCQX: FFNTF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

4Front Ventures (CSE: FFNT) (OTCQX: FFNTF) owns, operates and manages cannabis cultivation and production facilities. 4Front operates one of the largest cannabis-product manufacturing sites in the world in the state of Washington, with two >50,000-square-foot indoor cultivation facilities yielding upwards of 400g/sq. ft. alongside additional cultivation facilities located in the states of Massachusetts and Illinois. 4Front has specialized in the production of premium-quality flower, edibles and oil-based products and has developed considerable expertise at scale with multiple extraction methodologies, including CO2 and volatile solvents. Separately, and in addition to its manufacturing business, 4Front also currently owns and manages medical dispensaries…

WednesdayOct 14, 2020 10:30 am

Schwazze (OTCQX: SHWZ) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Schwazze (OTCQX: SHWZ), formerly knowns as Medicine Man Technologies, Inc., is creating a vertically-integrated platform in Colorado and beyond, which will comprised of a portfolio of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting and nutrients. Ultimately, the company intend to put together a series of businesses to create a premier cannabis-focused company consolidating the Colorado cannabis marketplace. Justin Dye, CEO & Chairman of Schwazze, will be delivering a keynote presentation alongside moderator Tony Noto, Cannabis Editor at Benzinga. To learn more about Schwazze, visit https://www.schwazze.com/ For registration information and further details on Benzinga’s Cannabis Capital Conference,…

WednesdayOct 14, 2020 10:25 am

GreenLane Holdings (NASDAQ: GNLN) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

GreenLane Holdings (NASDAQ: GNLN) is a holding company which, through its subsidiaries, supplies vaporization products and accessories to dispensaries and smoke shops across the United States and Canada. Since being founded in 2005, the company has grown to over 300 employees with operations in thirteen cities across North America and Europe, including seven highly automated distribution centers. Aaron LoCascio, CEO of GreenLane Holdings, and Bill Mote, CFO of GreenLane Holdings, will be participating in a forum entitled “High Tech: Technology Changing the Game for the Cannabis Consumer” together with Brian Cissell at 365 Cannabis and moderated by Michael Aiello of…

WednesdayOct 14, 2020 9:00 am

Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics

NetworkNewsWire Editorial Coverage: Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as "magic mushrooms." There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as…

TuesdayOct 13, 2020 2:01 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Takes Another Step Closer to Q1 Launch of Brain Cancer Drug Trial

CNS Pharmaceuticals is a pre-clinical-stage developer of novel brain cancer-fighting drugs, including its lead candidate Berubicin The company is working to build on promising results from a 2006 Phase I trial, which provided 44 percent of its limited patient pool with clinically significant improvement in disease stability and one patient with a durable complete response (no evidence of any tumor remaining) for over 14 years CNS Pharmaceuticals expects to launch a pivotal Phase II trial of Berubicin at the beginning of next year and has been assembling a team of partner companies help with the trial CNS recently announced that…

TuesdayOct 13, 2020 1:21 pm

Predictive Oncology Inc. (NASDAQ: POAI) CEO Schwartz Pens Letter to Shareholders, Elaborates on Ongoing Company Developments

Predictive Oncology’s CEO Carl Schwartz published open letter to company’s shareholders Schwartz elaborated on various developments within each of POAI’s divisions, has reiterated his optimism on company’s operations going forward CEO also revealed that company’s revenue trends have stabilized and are now on upward trend with cash burn beginning to decline Company also revealed its ability to access over $10 million in undrawn equity lines of credit Carl Schwartz, the CEO of Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has recently published a…

TuesdayOct 13, 2020 12:52 pm

Kaival Brands Innovations Group Inc. (KAVL) Acquires Patent, Announces Lab, Enters Smoking Cessation Market

KAVL recently acquired patent, announced creation of wholly owned subsidiary to develop smoking cessation products. Company plans to create products that satisfy smokers but are free from nicotine’s addictive traits. CEO says company is excited to help “all nicotine users lead healthier and higher-quality lives.” The Centers for Disease Control and Prevention report that smoking is the leading cause of preventable death in the world today (https://nnw.fm/SajJo). With the help of new and innovative cessation products, the 7 million deaths that occur every year due to smoking could be prevented — and Kaival Brands Innovations Group (OTCQB: KAVL) is determined to do…

Financial news and publishing for public and private companies

Contact us: 512.354.7000